1Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, South Carolina; 2Department of Pharmaceutical Sciences, College of Pharmacy, Presbyterian College, Clinton, South Carolina; and 3Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina
Reprint requests to: Michael D. Wyatt, PhD, Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, 715 Sumter St, Columbia, SC. E-mail: [email protected]
This study was funded by grant P20MD001770 from the National Institute on Minority Health and Health Disparities and by grant R21CA169998.
The CWCS study was approved by the institutional review board of the University of South Carolina. All participant information and samples were deidentified before the study reported here.
The authors have declared they have no conflicts of interest.
Role of the Funding Source: This study was funded by grant P20MD001770 from the National Institute on Minority Health and Health Disparities and by grant R21CA169998. The funding source had no involvement.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.jlgtd.com).
